UY32245A - Metodo para tratar trastornos del sueño usando eplivanserina - Google Patents

Metodo para tratar trastornos del sueño usando eplivanserina

Info

Publication number
UY32245A
UY32245A UY0001032245A UY32245A UY32245A UY 32245 A UY32245 A UY 32245A UY 0001032245 A UY0001032245 A UY 0001032245A UY 32245 A UY32245 A UY 32245A UY 32245 A UY32245 A UY 32245A
Authority
UY
Uruguay
Prior art keywords
eplivanserine
sleep disorders
treat sleep
eplivanserin
treat
Prior art date
Application number
UY0001032245A
Other languages
English (en)
Inventor
Prieur Amelie
Rein Werner
Verpillat Patrice
Weinling Estelle
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08291063A external-priority patent/EP2186511A1/en
Priority claimed from EP09290382A external-priority patent/EP2266554A1/en
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY32245A publication Critical patent/UY32245A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Método para tratar trastornos del sueño usando eplivanserina Método para proporcionar eplivanserina . Método para gestionar el riesgo para permitir un uso eficaz y seguro de la eplivanserina. Método para promover el uso de la eplivanserina. Artículo de fabricación y envase
UY0001032245A 2008-11-13 2009-11-13 Metodo para tratar trastornos del sueño usando eplivanserina UY32245A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11408208P 2008-11-13 2008-11-13
EP08291063A EP2186511A1 (en) 2008-11-13 2008-11-13 Method of treating sleep disorders using eplivanserin
US18109509P 2009-05-26 2009-05-26
EP09290382A EP2266554A1 (en) 2009-05-26 2009-05-26 Method of treating sleep disorders using eplivanserin

Publications (1)

Publication Number Publication Date
UY32245A true UY32245A (es) 2010-06-30

Family

ID=41600471

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032245A UY32245A (es) 2008-11-13 2009-11-13 Metodo para tratar trastornos del sueño usando eplivanserina

Country Status (8)

Country Link
US (1) US20120108669A1 (es)
EP (1) EP2365805A1 (es)
JP (1) JP2012508792A (es)
AR (1) AR074332A1 (es)
PA (1) PA8848501A1 (es)
TW (1) TW201023853A (es)
UY (1) UY32245A (es)
WO (1) WO2010055461A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2765107B1 (fr) * 1997-06-26 2000-03-24 Sanofi Sa Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
TW200626137A (en) * 2004-12-13 2006-08-01 Takeda Pharmaceuticals Co Preventive or therapeutic agent for sleep disorder
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
US20110077200A1 (en) * 2006-12-06 2011-03-31 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep

Also Published As

Publication number Publication date
EP2365805A1 (en) 2011-09-21
AR074332A1 (es) 2011-01-05
JP2012508792A (ja) 2012-04-12
TW201023853A (en) 2010-07-01
US20120108669A1 (en) 2012-05-03
PA8848501A1 (es) 2010-06-28
WO2010055461A1 (en) 2010-05-20

Similar Documents

Publication Publication Date Title
CY1123404T1 (el) Αντι-girt αντισωματα
CL2016002144A1 (es) Inhibidores de la jak1 para el tratamiento de síndromes mielodisplásicos.
UY34278A (es) Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
IN2015DN00895A (es)
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
CL2012001405A1 (es) Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer.
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
MX2012000034A (es) Metodos para el tratamiento o la prevencion de la fatiga.
MY169328A (en) Compositions for the treatment of dry eye
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
AR092899A1 (es) Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion
RS53893B1 (en) USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT
UY33461A (es) Compuestos heterocíclicos, su preparación y su aplicación terapéutica
WO2012158672A3 (en) Compounds for use in treatment of mucositis
WO2013016452A3 (en) Cancer treatment using bmp inhibitor
CO7151543A2 (es) Combinaciones terapéuticas y métodos para tratar el melanoma
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
CR20130610A (es) Método de tratamiento de la fiebre dengue
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
BR112018008931A2 (pt) ?compostos para tratamento de distúrbios hipoproliferativos?
WO2013070670A8 (en) Device for tendon and ligament treatment
PE20151574A1 (es) Metodo y reactor de esterilizacion

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130408